The association between serum uric acid and the prevalence of ECG abnormalities was analyzed for 24,997 employed men and women, white and black, age 18-64 years, from the Chicago Heart Association (CHA) Detection Project in Industry. In addition, the relationships between uric acid and 5-year mortality from all causes, from cardiovascular diseases (CVD), and from coronary heart disease (CHD) were analyzed for 7804 white men and women age 45-64 years from this study and 967 white men age 44-63 years from the Chicago People's Gas Company Study. For men, the associations between uric acid and the prevalence of ECG abnormalities and with mortality appear to be secondary to associations between uric acid and other risk factors. For women, however, the associations could not be explained by other risk factors.
A POSSIBLE ASSOCIATION of serum uric acid with risk of coronary heart disease (CHD) has been noted in several studies.' 7 Other reports have either not confirmed these findings8-10 or noted that the association disappears when controlling for relative weight or use of diuretics." '8 The importance of determining if uric acid is an independent risk factor for CHD derives in part from the hyperuricemic effects of diuretics and their widespread use in the treatment of hypertension."' An independent contribution of uric acid to CHD risk would necessitate re-evaluation of the benefit/risk ratio of the use of diuretics in hypertension, especially of the common less severe grades.
In this study we analyzed the association between serum uric acid and the prevalence of ECG abnormalities for 24,997 men and women, white and black, age 18-64 years, from the Chicago Heart Association (CHA) Detection Project in Industry. In addition, the relationships of baseline serum uric acid and mortality from all causes, from cardiovascular diseases (CVD) and from CHD are assessed for 7804 white men and women originally age 45-64 years from this same study, and for 967 white males age 44-63 years in 1962 from the Chicago People's Gas Company study.
Materials and Methods
From the fall of 1967 until early 1973, the Chicago Heart Association Detection Project in Industry screened 39,665 young adult and middle-aged men and women, both black and white, employed in 85 firms in the Chicago area. The volunteer rate for this screening effort was 55%. In all facilities, all employees were encouraged to participate regardless of the type of job or shift worked. At each site of employment, standardized tests were administered by one of two specially trained four-person teams of nurses and technicians. They included a selfadministered questionnaire to collect demographic data and information on chronic diseases; measurements of height and weight; a single casual supine blood pressure reading (standard mercury sphygmomanometer, fifth phase diastolic pressure); venipuncture for determination of serum cholesterol, uric acid and plasma glucose 1 hour after a 50 g oral load; and an ECG. Relative weight was computed as the ratio of observed body weight to desirable weight for height and sex, based on 1959 actuarial tables from the Metropolitan Life Insurance Company.20' 21 Methods of chemical analyses have been described previously.22 Heart rate was determined from the ECG. Electrocardiographic abnormalities were divided into major and minor by criteria of the Hypertension Detection and Follow-up Program (HDFP), which are a slight modification of the criteria of the National Cooperative Pooling Project.23 A detailed description of criteria for major ECG abnormalities is given in the Appendix.
Of the group screened, 37,604 were age 18-64 years. The group of 24,997 men and women with complete baseline data on all relevant variables and not hypertensitives on drug treatment are examined in this report for possible associations at baseline between serum uric acid and electrocardiographic abnormalities.
For this study, 7804 white men and women age 45-64 years, free of definite CHD at baseline and followed for an average of 5 years, were examined for possible associations between serum uric acid and mortality from all causes, CVD and CHD. Cause of death was determined from the death certificate and classified according to the eighth revision of the 969 VOL 59, No 5, MAY 1979 Abbreviation: NA = not appropriate because there were less than five cases in at least one uric acid group.
CIRCULATION
Serum uric acid was not measured in this study until 1962, when 1106 men from the original cohort of 1465 were reexamined. Details of this examination have been published elsewhere. 26 Of these men, 967 were white, age 44-63 years and free of definite CHD in 1962. Data on treatment for hypertension were not available on these men, who have been followed for 13 years. The associations between serum uric acid and mortality from all causes, CVD, CHD and stroke were examined. Cause of death was determined primarily from the death certificate, with classification by a combination of the seventh and eighth revisions of the ICDA. Autopsy and hospital reports were also used when available. The data are analyzed using both univariate and multivariate techniques. The univariate techniques include cross-classification with chi-square analysis when appropriate, and t tests of the difference in uric acid means between those with and without ECG abnormalities and between those who survived and those who died. The multivariate analysis was based on multiple linear regression. In all instances the statistical software package developed by the Statistical Package for the Social Sciences was used.27
Results

Serum Uric Acid and Prevalence of Electrocardiographic Abnormalities: Chicago Heart Association Detection Project in Industry
The correlations of serum uric acid with other baseline variables for each age-sex-race group of the CHA cohort are shown in table 1. Uric acid correlates most strongly with relative weight. Correlations with diastolic and systolic blood pressure are somewhat lower. Associations are less strong with heart rate, age, glucose and cholesterol.
The prevalence rates of electrocardiographic abnormalities for both major and any abnormalities, by uric acid level for each age-sex-race group, are shown in table 2. In several of the groups, the abnormality rate is significantly higher for the group with the highest uric acid, suggesting a threshold effect. Based on the chi-square test, the differences reach statistical significance (p < 0.05) for major abnormalities in white men age 45-64 years, for all abnormalities in black women age 25-44 years, and for major and all abnormalities in white women 45-64 years.
The mean serum uric acid of those persons with and Abbreviations: CVD = cardiovascular disease; CHD = coronary heart disease. years and 45-64 years. Uric acid differences in black women age 18-24 years became significant after adjustment for all variables with major abnormalities as the end point.
Baseline Serum Uric Acid and 5-year Mortality: Chicago Heart Association Detection Project in Industry
Five-year mortality rates by level of serum uric acid at baseline from all causes, CVD and CHD for white men age 45-64 years and for white women age 45-64 years are shown in table 4. The numbers of total and cause-specific deaths in the other age-sex-race groups are too small for a meaningful examination of the questions considered here, e.g., there were no CHD deaths in any of the groups of black women, in black men younger than 45 years or in white men and women younger than 25 years. In addition, none of the other groups had more than six CHD deaths.
There is a tendency in white men age 45-64 years for all-cause mortality to be higher in the highest uric acid group. This tendency persists when hypertensives on treatment are excluded. Correspondingly, CVD and CHD death rates are also higher in men in the highest uric acid groups. This tendency does not persist as strongly when hypertensives on treatment are excluded. In white women age 45-64 years the highest death rate from all causes occurred in the group with uric acid 6.0-6.4. Cause-specific mortality data in white women age 45-64 years are shown for completeness. The numbers, however, are too small for meaningful comparison.
Mean serum uric acid levels by sex and cause of death are shown in table 5. T tests of significance are computed for the differences in means between those who died and those who were still alive at the time of analysis. T tests, adjusted for age differences, and for differences in age, serum cholesterol, plasma glucose, relative weight, heart rate, systolic blood pressure and number of cigarettes smoked per day are also given.
Mean uric acid levels of men who died from all causes, CHD and CVD are significantly higher than mean uric acid values of men who survived. These differences persist for death from all causes, but not for death from CVD or CHD when controlled for differences in the other variables. These differences do not persist if hypertensives on treatment are excluded. The mean serum uric acid of women who died from any cause is significantly higher than the mean serum uric acid of women who survived. This difference persists when adjusted for all other variables and when hypertensives on treatment are excluded from the analysis. For these women, the uric acids of those who died from CVD or CHD tended to be higher than the uric acids of those who survived, but given the small numbers, the differences are not statistically significant.
Baseline Serum Uric Acid and 13-Year Mortality: Chicago People's Gas Company Study
Thirteen-year mortality rates by baseline serum uric acid of white males age 44-63 years from the Chicago People's Gas Company Study are shown in table 6. There are no consistent trends in either total or causespecific mortality, although the all-cause, CVD and CHD death rates are higher in those with uric acid . 8 mg/dl. Mean serum uric acid by vital status and cause of death, with t tests of significance of the difference between the means of those who died and those who survived 13 years, are shown in table 7. Also noted are the t tests of significance for uric acid differences adjusted for age, and for age, pulse, serum cholesterol, relative weight, systolic blood pressure and number of cigarettes smoked per day. There are no significant differences at the 0.05 level in a two-tailed test, although death from all causes and stroke approach significance (p < 0.10) controlling for other variables.
Discussion
The possible association of elevated serum uric acid with coronary heart disease has been controversial. In 1951 Gertler et al. reported higher mean serum uric acid levels in young men with CHD compared with healthy controls.' Several other case-control studies with small numbers of persons confirmed these findings.' '7 Larger epidemiologic studies, however, have yielded conflicting results. An Israeli prevalence study found no association of uric acid with CHD on univariate analysis.9 However, an Australian prevalence study did note an association of uric acid with CHD in men, but not in women.4 This association persisted when other variables were controlled, but diuretic usage was not mentioned. Similarly, incidence data from Honolulu showed significant associations of baseline uric acid with CHD in 2 years of follow-up, which persisted on multivariate analysis.6 This study also failed to control for diuretic use. In contrast, in several other studies, apparent associations of uric acid with CHD were secondary to associations with other risk factors. In the Framingham study, significant associations in women were noted in some age groups between baseline uric acid and 16-year incidence of CVD." Except for an in- 974 CI RCULATION URIC ACID AND CHD/Persky et al. Abbreviations: CVD cardiovascular disease; CHD = coronary heart disease. creased incidence of myocardial infarction in men age 65-74 years with elevated uric acid, no associations with uric acid were noted in men. None of the associations persisted in multivariate analyses. 12 In the Tecumseh Study, no association was found between uric acid and CHD prevalence with age and weight controlled.'3 In the Evans County study, a significant association was noted between uric acid and CHD prevalence for white women and black men. These associations were not significant with blood pressure and cardiovascular medication controlled."
Four recent studies have found that the apparent association of uric acid with CHD may be secondary to use of diuretics. Prevalence data from the Honolulu study excluding men on diuretic therapy showed no correlation between uric acid and CHD on multivariate analysis.'8 Isomaki in Finland found higher uric acid levels in patients hospitalized with CHD than in healthy rural persons; this difference was not present when men on diuretic medication were excluded. 15 Similarly, Bengtsson and Tibblin from Goteborg noted that the higher uric acid levels in women age 50-54 years with "coronary" ECGs were secondary to diuretic usage.'6 Finally, the Coronary Drug Project Research Group, studying men age 30-64 years with prior evidence of myocardial infarction, noted that uric acid was a predictor of long-term mortality only if diuretic usage was not controlled. '7 In this study we have tried to determine if uric acid is an independent risk factor for the atherosclerotic diseases, i.e., after control for other risk factors including diuretic usage. The results in men are consistent with most,"1'8 but not all,4 6 other epidemiological studies. The data from the Chicago People's Gas Company study presented here indicate no statistically significant associations between baseline serum uric acid and 13-year mortality from all causes, CVD or CHD, although the association with all causes and stroke are nearly so. Prevalence data from the CHA Detection Project in Industry showed no association between uric acid and electrocardiographic abnormalities in black men. Data from the CHA study in white men age 45-64 years did show an association between uric acid and prevalence of electrocardiographic abnormalities, and between uric acid and death from all causes, CVD, and CHD. However, these latter associations did not persist after control for use of diuretics or for other baseline variables. tt values for the difference in mean uric acid between those who are still alive and those who have died. tt values of the uric acid coefficients in multiple linear regression controlling for age. §t values of the uric acid coefficients in multiple linear regression controlling for age, pulse, cholesterol, systolic blood pressure, relative weight and number of cigarettes smoked per day.
Abbreviations: CVD = cardiovascular disease; CHD = coronary heart disease. 975 VOL 59, No 5, MAY 1979 There is thus little evidence in these Chicago studies to support the hypothesis that in white men age 45-64 years uric acid is an independent risk factor for coronary artery disease. Prevalence data in white and black women and mortality data in white women from the CHA Detection Project in Industry show an association of uric acid with prevalence of ECG abnormalities and with all-cause mortality. This possible association of-uric acid with all-cause mortality in white women is unexplained. It may be secondary to low-order associations with CHD, CVD or cancer, which do not reach statistical significance because of small numbers. It does not appear, in contrast to previous literature,19 to be secondary to diuretic usage or to associations with other measured variables such as relative weight, glucose, cholesterol, blood pressure, age, heart rate or smoking.
Findings from this study do not support the hypothesis that uric acid is an independent risk factor for CHD in white men 45-64 years. Associations of uric acid with prevalence of electrocardiographic abnormalities and with incidence of CHD in white men 45-64 years appear to be secondary to associations with other variables such as diuretic usage, blood pressure and relative weight. In white women the positive associations between uric acid and ECG abnormalities, and in white women 45-64 years the positive association between uric acid and death from all causes, suggest that uric acid may be an independent risk factor for CHD in women. These associations did not appear to be secondary to other measured variables and are unexplained. Further investigations are needed to clarify these findings. tual prevalence of ischemic abnormalities has been found to be lower with combined static-dynamic effort than with dynamic effort alone.3' 4 These studies have reported the heart rate-systolic blood pressure product, or "double product," only during peak staticdynamic effort3 1 4or during a fixed submaximal work load,3 but not at the onset of ischemic ST-segment depression or angina pectoris. Consequently, we do not know whether the double product at which ischemic abnormalities appear with dynamic effort is the same as that at which ischemic abnormalities appear with combined static-dynamic effort. Moreover, a systematic difference between the double product at the onset of ischemic abnormalities during these two modes of effort may imply a significant difference in mechanisms underlying myocardial ischemia.
We had three aims in this study: 1) to devise a simple, standardized and clinically useful method for
